At the World Economic Forum, CEO Stéphane Bancel expressed concern about the US vaccine market but remained committed to ...

Amid growing evidence suggesting circadian rhythms play a critical in the safety and efficacy of CAR T-cell therapy, ...

NEW YORK – Ocugen said on Friday that it has raised about $22.5 million in a recent public offering.

The bills would require insurers to cover germline multi-gene testing for inherited cancer risk and imaging with no out-of-pocket cost for patients.

Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...

NEW YORK – Neok Bio on Thursday said it has been cleared by the US Food and Drug Administration to begin a Phase I trial of its bispecific antibody-drug conjugate (ADC) NEOK001 in solid tumors.

Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.

The partners will use 4D Path's imaging-based Q-Plasia OncoReader in a Phase II trial testing doublet and triplet regimens comprising Trodelvy, Padcev, and Keytruda.

NEW YORK – Bristol Myers Squibb and Janux Therapeutics on Thursday announced they will jointly develop an undisclosed tumor-activated therapeutic targeting a validated solid tumor antigen expressed ...

NEW YORK – Boston Children's Hospital has granted a worldwide license for an investigational gene therapy for sickle cell disease and beta thalassemia to Caring Cross, the nonprofit announced this ...

All patients with autoimmune hemolytic anemia in a small study initially achieved remission, though two eventually relapsed, ...

After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...